Clinical profiles of patients with primary sclerosing cholangitis in the elderly
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: In 2012 we conducted a nationwide survey for primary sclerosing cholangitis (PSC) and isolated IgG4‐related sclerosing cholangitis (IgG4‐SC) in J apan, and demonstrated the young as well as the elderly individuals were at higher risk for development of PSC. In the current study we aimed to further clarify the clinical profiles of PSC in the elderly, compared with PSC in the young and IgG4‐SC. Methods: The design was a questionnaires‐based, multi‐center retrospective study. The enrolled subjects were patients with PSC and isolated IgG4‐SC diagnosed after 2005. Since the median of age of patients with PSC was 48.1, we defined those who developed the disease at the age older than 48.1 as PSC in the elderly, and the rest as PSC in the young. Results: We defined 98 and 99 patients as PSC in the elderly and in the young, respectively. Although symptoms and biochemistries at presentation were similar, serum IgA and IgM levels were significantly higher and lower in the elderly PSC compared to the young PSC, respectively (P < 0.001, P < 0.001). The sensitivity and specificity of serum IgG4 levels were 89.5% and 88.9% for discriminating the elderly PSC and IgG4‐SC. In terms of complications, prevalence of IBD was 12% in the elderly PSC and 57% in the young PSC, the latter being comparable to those in Europe and the USA. Conclusion: It is reasoned to conclude that PSC in the young resembles those in Europe and the USA in terms of the onset age and prevalence of IBD, while PSC in the elderly is really unique in J apan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Kaplan, G. G., Laupland, K. B., Butzner, D., Urbanski, S. J., & Lee, S. S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01103.x · Cited by 273
Cited by
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Genetics of primary sclerosing cholangitis and pathophysiological implications
Jiang, X., & Karlsen, T. H. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.154 · Cited by 155
Kumagai, J., Taida, T., Ogasawara, S., Nakagawa, T., Iino, Y., Shingyoji, A., Ishikawa, K., Akizue, N., Yamato, M., Takahashi, K., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209352 · Cited by 29
ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis
Yao, Q., Wang, B., Yu, J., Pan, Q., Yu, Y., Feng, X., Chen, W., Yang, J., Gao, C., & Cao, H. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.006 · Cited by 24
Metadata
- Authors
- Tanaka, A., Tazuma, S., Okazaki, K., Tsubouchi, H., Inui, K., & Takikawa, H.
- Venue
- Journal of Hepato-Biliary-Pancreatic Sciences
- Publisher
- Wiley
- Published
- 2014-11-19
- Volume
- 22
- Issue
- 3
- Pages
- 230-236
- ISSN
- 1868-6974 (ISSN-L)
- 1868-6982
- OpenAlex
- W2086809583
- Cited by
- 23
- References
- 3
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical profiles of patients with primary sclerosing cholangitis in the elderly. https://app.cochat.ai/papers/10.1002/jhbp.194
- The paper
- Tanaka, A., Tazuma, S., Okazaki, K., Tsubouchi, H., Inui, K., & Takikawa, H. (2015). Clinical profiles of patients with primary sclerosing cholangitis in the elderly. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.194
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.